glp-1 gip dual agonist glp 1 and receptor Major physiological roles of and GIP. Tirzepatide is acting as an Tirzepatide's Unique Mechanism of Action

However, medical professionals emphasize the need for careful screening and monitoring to avoid potential risks in non-diabetic use

Instead, the results suggest that GLP-1 receptor activation may influence brain pathways beyond its effects on weight loss and glucose control

SURMOUNT-4 provided the strongest evidence for continued treatment

While BP reduction is not their primary indication, GLP-1 RAs are increasingly prescribed to patients with T2DM, obesity, and metabolic syndrome, which are populations in which hypertension is common and often difficult to control

Improvements in steatosis and hepatocyte ballooning scores were also observed

Medical professionals must educate patients about potential injection-site reactions and hypersensitivity reactions, which could lead to autoimmune conditions like pyoderma gangrenosum and BP [33,41,73]